New York · 88188

Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in New York

New York Medicare Avg
$51.69
7% above national avg
National Medicare Avg
$48.39
All states combined
Billed Charge (NY)
$367.63
What providers submit
Est. Commercial (NY)
$164.15
National avg: $138.37
Est. Cash / Self-Pay (NY)
$150.34
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

3.8K
Services in NY
154
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in New York

Provider Medicare Services
Esoterix Genetic Laboratories, Llc $54.38 115
Ouseph, Madhu MD PHD $53.34 86
Geyer, Julia M.D. $54.82 82
Northwell Health Laboratories $46.37 40
Plocharczyk, Elizabeth MD $45.12 27
Huho, Albert MB, CHB $47.58 26
Cblpath, Inc $55.37 24
Lin, Oscar MD $54.41 20
Brandt, Suzanne MD $49.73 14
Cairo Diagnostics,llc $55.37 11

New York Pricing in Context

In New York, CPT code 88188 (Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers) carries an average Medicare payment of $51.69 — 7% above the national benchmark of $48.39. 154 providers across the state submitted claims for this procedure in 2023, performing 3.8K total services. Individual payments in NY ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in New York is $367.63, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New York sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Genetic/Molecular Test procedures, the estimated commercial insurance price in New York lands near $164.15, with self-pay cash prices typically around $150.34. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cost in New York?

The average Medicare payment for Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in New York is $51.69, which is 7% above the national average of $48.39. Providers in NY typically bill $367.63 for this procedure.

What does Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cost with insurance in New York?

With commercial insurance in New York, Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers costs an estimated $164.15. Without insurance, the estimated cash price is $150.34. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in New York?

154 providers in New York billed Medicare for Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in 2023, performing 3.8K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cheaper in New York than the national average?

No — Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers costs 7% above the national average in New York. The state average Medicare payment is $51.69 compared to $48.39 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial